Numerate Trains Its Drug Design Platform On Huntington’s Disease Bernadette Tansey, xconomy.com Bernadette TanseyThe path toward a breakthrough drug often starts with a new insight about the molecular cause of an illness, but only a few of these discoveries lead to new treatments. Steven Finkbeiner at the Gladstone Institutes in San… http://flip.it/Ivquf Related articles Drug … Continue reading Numerate applies big data to drug design
You must be logged in to post a comment.